Holly graduated with a Master of Chemistry degree in 2010 and a DPhil in Inorganic Chemistry at the University of Oxford in 2015. From 2016, she led an Innovate UK research program taking a biotechnology, HydRegen, from proof-of-concept results to commercial offering as a spinout with more than £3.5m private investment to-date. The technology promises to transform biocatalysis in chemical manufacturing, allowing isolated enzymes to be handled in the same way as supported metal catalysts for hydrogenation reactions. As CEO at HydRegen, her vision is to provide robust biotechnologies that tackle energy and resource efficiency, increase uptake of continuous manufacturing and support growth of circular and bio-based economies across the chemicals sector.